Abstract | OBJECTIVE: DESIGN: This prospective, randomized placebo-controlled trial included 57 patients (90 median nerves). Ninety median nerves were randomly assigned to 1 of 3 groups: group 1 was injected with 1 ml 0.09% saline, group 2 was injected with 40 mg triamcinolone acetonide, and group 3 was injected with 4 ml 1% procaine HCl. Clinical and electrophysiological evaluations were performed at study onset, and at 2 and 6 months post-treatment. RESULTS: At study onset no significant differences were observed between groups with respect to clinical and electrophysiological parameters. Clinical and electrophysiological evaluations was improved significantly in groups 2 and 3 at post-treatment (p<0.05). No significant changes were observed in group 1 (p>0.05). Moreover, groups 2 and 3 had better scores than group 1 at 2 and 6 months post-treatment(p<0.05). There was no difference between groups 2 and 3 in terms of change scores of any terms at post-treatment (p>0.05). CONCLUSION:
|
Authors | Ömer Karadaş, Fatih Tok, Selim Akarsu, Levent Tekin, Birol Balaban |
Journal | Journal of rehabilitation medicine
(J Rehabil Med)
Vol. 44
Issue 7
Pg. 601-4
(Jun 2012)
ISSN: 1651-2081 [Electronic] Sweden |
PMID | 22674243
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Adrenal Cortex Hormones
- Anesthetics, Local
- Anti-Inflammatory Agents
- Procaine
- Triamcinolone Acetonide
|
Topics |
- Adrenal Cortex Hormones
(therapeutic use)
- Anesthetics, Local
(therapeutic use)
- Anti-Inflammatory Agents
(therapeutic use)
- Carpal Tunnel Syndrome
(drug therapy)
- Female
- Humans
- Male
- Median Nerve
- Middle Aged
- Pain Measurement
- Procaine
(therapeutic use)
- Triamcinolone Acetonide
(therapeutic use)
|